Octreotide efficacy in the treatment of chylothoraces following cardiac surgery in infants and children

Pediatric Critical Care Medicine

Volumn 7, Issue 3, 2006, Pages 245-248

  Landvoigt, Maple T ^a   Mullett, Charles J ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac surgery; Chylothorax; Octreotide; Pediatric; Postoperative

Indexed keywords

OCTREOTIDE;

CHILD; CHYLOTHORAX; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; DRUG EFFICACY; HEART SURGERY; HUMAN; INFANT; PEDIATRIC SURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 33646892179     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000216683.00110.0E     Document Type: Article

References (17)

1. Doerr CH, Allen MS, Nichols FC, et al: Etiology of chylothorax in 203 patients. Mayo Clin Proc 2005; 80:867-870
2. Beghetti M, La Scala G, Belli D, et al: Etiology and management of pediatric chylothorax. J Pediatr 2000; 136:653-658
3. Kabbani MS, Giridhar S, Elbarbary M, et al: Postoperative cardiac intensive care outcome for Down syndrome children. Saudi Med J 2005; 26:943-946
4. Marts BC, Naunheim KS, Fiore AC, et al: Conservative versus surgical management of chylothorax. Am J Surg 1992; 164:532-535
5. Rimensberger PC, Muller-Schenker B, Kalangos A, et al: Treatment of a persistent postoperative chylothorax with somatostatin. Ann Thorac Surg 1998; 66:253-254
6. Cheung Y, Leung MP, Yip M: Octreotide for treatment of postoperative chylothorax. J Pediatr 2001; 139:157-159
7. Buettiker V, Hug MI, Burger R, et al: Somatostatin: a new therapeutic option for the treatment of chylothorax. Intensive Care Med 2001; 27:1083-1086
8. Mohseni-Bod H, Macrae D, Slavik Z: Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: Is it safe? Ped Crit Care Med 2004; 5:356-357
9. Pratap U, Slavik Z, Ofoe V, et al: Octreotide to treat postoperative chylothorax after cardiac operations in children. Ann Thorac Surg 2001; 72:1740-1742
10. Lam JC, Aters S, Tobias JD: Initial experience with octreotide in the pediatric population. Am J Ther 2001; 8:409-415
11. Pettitt T, Caspi J, Borne A: Treatment of persistent chylothorax after Norwood procedure with somatostatin. Ann Thorac Surg 2002; 73:977-979
12. Aleo Lujan E, Uran Moreno MM, Brandstrup Azuero KB, et al: Octreotide treatment of post surgical chylothorax. Ann Pediatr (Barc) 2003; 58:390-392
13. Al-Zubairy SA, Al-Jazairi AS: Octreotide as a therapeutic option for management of chylothorax. Ann Pharmacother 2003; 37:679-678
14. Matsuo T, Matsumoto M, Sugita T, et al: Treatment of persistent chylothorax with somatostatin. Ann Thorac Surg 2003; 76:340-341
15. Hamdan MA, Gaeta ML: Octreotide and low-fat breast milk in postoperative chylothorax. Ann Thorac Surg 2004; 77:2215-2217
16. Rosti L, Bini RM, Chessa M, et al: The effectiveness of octreotide in the treatment of post-operative chylothorax. Eur J Pediatr 2002; 161:149-150
17. Agresti A, Coull BA: Approximate is better than "exact" for interval estimation of binomial proportions. Am Statistician 1998; 52:119-126